NCT03525028 is a NA clinical trial of Metformin in Uveitis, sponsored by Tianjin Medical University.

Who is sponsoring NCT03525028?

NCT03525028 is sponsored by Tianjin Medical University.

What drugs are being tested in NCT03525028?

Interventions in NCT03525028: Metformin, Placebo.

What condition does NCT03525028 study?

NCT03525028 studies Uveitis, Metformin, Glucocorticoid.

Is NCT03525028 still recruiting?

NCT03525028 is currently status unknown. Last updated 6 May 2022.

Last reviewed 2022-05-06 · How we verify

NCT03525028

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Clinical Trial of Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune Uveitis

Status unknown NA Last updated 6 May 2022

What this trial tests

NA trial testing Metformin in Uveitis in 138 participants. Status unknown.

Timeline

1 November 2018

Primary endpoint
1 January 2023

1 January 2023

Quick facts

Lead sponsor	Tianjin Medical University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	138
Start date	1 November 2018
Primary completion	1 January 2023
Estimated completion	1 January 2023
Sites	1 location across China

Drugs / interventions tested

Metformin (metformin) — full drug profile →
Placebo

Conditions studied

Uveitis — all drugs for Uveitis →
Metformin — all drugs for Metformin →
Glucocorticoid — all drugs for Glucocorticoid →

Sponsor

Tianjin Medical University

Who can join

Adults 18 to 80, any sex, with Uveitis or Metformin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project is designed to evaluating the use of combination therapy of glucocorticoid and metformin to decrease glucocorticoid side effects in participants with autoimmune uveitis.This study also aims to evaluate the anti-inflammatory and immunosuppressive effects of combination therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Metformin

Trials testing the same drug.

NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
NCT07520110 — Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis · Phase 3 · not yet recruiting
NCT07007221 — Clinical Trials to Evaluate Metformin to Treat Depression in People Living With HIV · Phase 2 · not yet recruiting
NCT07585396 — Inositol in Letrozol Resistant PCOS Women · Phase 2, PHASE3 · not yet recruiting
NCT07226453 — Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma · Phase 2 · not yet recruiting

Other recruiting trials for Uveitis

Currently open trials in the same condition.

NCT07262437 — Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles · NA · active not recruiting
NCT07176130 — Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore · active not recruiting
NCT06974162 — Metagenomics for Ocular Inflammation · recruiting
NCT06431373 — A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis · Phase 3 · active not recruiting
NCT06310837 — Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis · NA · active not recruiting

Other Tianjin Medical University trials

Trials by the same sponsor.

NCT07393685 — Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPD · not yet recruiting
NCT07306598 — [18F]NIDF PET Imaging in Tau-related Diseases · recruiting
NCT07232459 — [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis · recruiting
NCT06949670 — Alpha-Synuclein PET/CT in Various α-Syn-Related Disease · recruiting
NCT06628531 — ALI & Pulmonary HA Deposition After SAH · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03525028 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tianjin Medical University
Last refreshed: 6 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03525028.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing